Grifols Approves IPO for US Biopharma Business

Grifols, a global healthcare company, has approved an initial public offering (IPO) for a segment of its biopharma business located in the United States, following earlier considerations.

24 Mar, 21:11 — 24 Mar, 21:11

Post Share

Sources

Showing 1 of 4 sources

ReutersVery High160d ago

Grifols approves IPO of its US biopharma business - Reuters

Grifols approves IPO of its US biopharma business Reuters

Read full article →

Coverage Timeline

First report: Reuters · 24 Mar, 21:11|Full coverage: 4 · 1h|Window: 1h

Left-leaningCenterRight-leaning

Reuters24 Mar, 21:11First to report

Grifols Approves IPO for US Biopharma Business

Sources

Grifols approves IPO of its US biopharma business - Reuters

Coverage Timeline

Grifols approves IPO of its US biopharma business - Reuters

Grifols considers IPO of part of its US biopharma business

Grifols sacará bolsa su negocio de Biopharma en Estados Unidos

Grifols prepara la salida a bolsa de su negocio de Biopharma en Estados Unidos

Related Stories

Travis Kelce Stars in First Major Campaign for Tommy Hilfiger

Nvidia Invests $3.5 Billion in MediaTek to Expand AI Chip Capabilities

Shein’s Hong Kong Stock Debut Falls Amid Investor Concerns and Regulatory Scrutiny

Eurozone Inflation Rises to Three-Year High Amid Energy Price Surge